Living with difference: Refugee education and school segregation processes in Greece

Global challenges and recent changes in conflict areas in the Middle East, Asia and Africa are reasons for the contemporary forced migration into European countries, which have become places of destination or transit posts for a great number of refugees. Cities have become the focus of the socio-spatial debate, as the main units for receiving refugees, either in state camps or in social housing in city centres. In this article, the focus is on the social-spatial configuration of refugee accommodation in local communities and the way these formations generate urban and school segregation. We argue that the placement of urban refugees in large, camp-like structures with low housing standards, mainly in areas outside cities or in rural areas, provides ground not only for social exclusion and ‘territorial stigmatisation’ but also for de facto school segregation. Furthermore, the attempts to house refugees in small cities, through United Nations and NGO-supplied houses, may also raise concerns about the way dispersal policies are implemented, with the distribution of refugee children in specific schools as a result of territorial social-spatial segregation. In both cases, the school segregation of refugees is connected not only with the implications of immigration and education policies but also with the social practices of local communities and the social-spatial characteristics that determine school education. The empirical material of this study is based on information on the socio-economic profiles of neighbourhoods at the census tract level and on qualitative research, through in-depth semi-structured interviews in two different cities in Greece. © Urban Studies Journal Limited 2019

Refugee mobilities and institutional changes: Local housing policies and segregation processes in greek cities

Many studies have explored the dynamics of immigrant and refugee settlement at the local level, highlighting that it is actually a two-way process: On the one hand, the local socio-political context specifies the conditions for refugee inclu-sion, and on the other, migrant mobility leads to the transformation of localities in various ways. In Greek cities, the social practices of local actors have played an important role in the implementation of the immigration policy, where refugees were perceived as a threat to personal and community security. Yet, new forms of social mobilisation and solidarity by indi-vidual citizens and community initiatives have worked to alter these attitudes, mitigating tensions and obstacles in refugee acceptance. The article draws on the Greek experience to explore the role and importance of the local socio-political tex-ture in refugee inclusion, shedding light on how it gave rise to various local initiatives that inform refugee allocation as well as urban transformation and institutional change. In methodological terms, the article considers three neighbouring Greek cities as case studies to identify the different institutional and policy responses to refugee accommodation, giving rise to different paths and forms of social inclusion. The study reveals the complexity and context of the social-spatial diversity that refugees face but also the transformation dynamics of local states and civil society. © 2021 by the authors;

Attitudes Towards Refugees & Immigrants in Greece: a national-local comparative analysis

Over the past decade, Greece has received a significant number of immigrants, refugees, and asylum seekers who, due to specific decisions taken at both the EU and the national levels, have been “trapped” in Greece for an indefinite period. Dealing with this situation was, and still is, a hot issue, with state policies remaining focused on reception and control rather than on integration. Moreover, the spatial allocation of refugees in specific places throughout the country raised further debate, as they often provoked reactions (of substantial political costs), given that different localities tend to exhibit different attitudes and views towards refugees and immigrants. Since these perceptions seem to exert a significant effect on the direction of public debate and state policy there have been a number of nationwide surveys that have sought to shed light on them. These studies certainly advance our understanding on how Greeks in totality perceive those issues, but they also suffer from serious limitations regarding the specificities that different localities exhibit. On their grounds, the current works seek to provide a comparative analysis between the results of a nation-wide survey and a locally contacted one, contrasting perceptions between people living in Athens metropolitan area and in three small-medium size cities in central Greece (Trikala, Larisa, and Volos), in order to identify similarities and differences in views between the different spatial scales. © 2021. by the authors

Coping with bullying" program in Greek secondary schools: An evaluation

[No abstract available

Association of thyroid autoimmunity with acne in adult women

Background During the last decades an increase has been observed regarding acne in adults and especially women. Objective To evaluate the association between thyroid disorder and the presence of post-adolescent acne in adult women, comparing with healthy controls. Methods 107 adult women with post-adolescent acne and 60 healthy controls were included. Complete blood count and standard biochemical profile of C-Reactive Protein (CRP) and levels of thyroid hormones and antibodies [ triiodothyronine (T3), thyroxine (T4), thyroid stimulating hormone (TSH), free T3 (FT3), free T4 (FT4), antithyroglobulin antibodies (anti-TG) and anti-thyroid peroxidase antibodies (anti-TPO)] were determined in all subjects of both the acne and control groups. A thyroid ultrasound was also performed. Results There was a statistically significant difference (P = 0.008) in the prevalence of positive anti-TG antibodies, with 25.2% of the acne group and 8.3% of the control group having elevated (> 40 U/ mL) anti-TG levels, respectively. Adult women with acne had a statistically significant increased relative risk to have high levels of antiTG in comparison with healthy controls (odds ratio 3.89, P = 0.011). This association was independent of age. Values for TSH, FT4, FT3, T4 and anti-TPO did not significantly differ between the two groups. No significant difference was found regarding the thyroid ultrasound findings. Although there was no significant difference between cases and controls regarding CRP levels, it is interesting that we observed a significant elevation in CRP in those acne patients who had positive antithyroglobulin antibodies. Conclusions It is likely that thyroid autoimmunity might be more frequent in the adult acne patients and this should be kept in mind when screening women with post-adolescent acne

Infliximab for the treatment of psoriasis in Greece: 4 years of clinical experience at a single centre

Background Infliximab, a chimeric monoclonal antibody, has been shown to be effective for moderate to severe psoriasis. Clinical experience with long-term infliximab therapy for psoriasis is accumulating, and it is therefore important to share our experience with its use in real-life clinical practice. Objectives To report our experience with infliximab (Remicade®; Schering Plough, Kenilworth, NJ, U.S.A.) for the treatment of moderate to severe plaque psoriasis (and/or arthritis) from a single clinic in Greece. Patients and methods Between August 2004 and March 2008, 62 patients presenting to our clinic with moderate to severe psoriasis were treated with infliximab. Disease phenotype, clinical course, disease severity and adverse events were assessed throughout the treatment period. Results Infliximab resulted in a reduction of median Psoriasis Area and Severity Index (PASI) of 70% at week 6 and 84·4% at week 14. Nineteen patients who have completed 1 year on infliximab treatment experienced sustained efficacy with a median PASI improvement of 92·16% and a Physician's Global Assessment (PGA) of 'clear' or 'almost clear', while nine patients have reached approximately 20 months of continuous therapy. All patients with psoriatic arthritis showed marked improvement in their clinical symptoms following the first infusion. Eight patients (12·9%) experienced adverse events that required discontinuation of treatment. There were no statistically significant differences in PASI and Dermatology Life Quality Index (DLQI) scores between patients with arthritis and those with only skin lesions, or between those who received methotrexate, either from the beginning or during infliximab therapy, and those who did not receive methotrexate at all. Selected patients of interest are discussed. Conclusions The above data confirm previous reports that treatment with infliximab is an efficacious and safe option for patients with moderate to severe plaque psoriasis (and/or arthritis). Long-term follow-up, continued pharmacovigilance, and controlled comparative studies will be required to fully evaluate its use in the treatment of psoriasis. © 2010 British Association of Dermatologists

A multicenter, prospective, observational study examining the impact of risk factors, such as BMI and waist circumference, on quality of life improvement and clinical response in moderate-to-severe plaque-type psoriasis patients treated with infliximab in routine care settings of Greece

Background: Obesity has been associated with moderate-to-severe plaque psoriasis severity and PASI 75 response attainment of biologic therapies, but findings are inconsistent. Objective: This study aimed to examine the association of body mass index (BMI) and waist circumference (WC) on disease severity, to identify potential patient characteristics associated with response attainment and to assess the impact of infliximab on the patients’ health-related quality of life (HRQoL) among infliximab-treated patients in the routine care setting of Greece. Methods: This was a multicenter, prospective, observational study of adult moderate-to-severe plaque psoriasis patients who had initiated treatment with originator infliximab within 2 weeks prior to enrolment. Postenrolment visits occurred at 14 ± 4, 30 ± 4 and 54 ± 4 weeks following treatment onset. Results: Between October 2012 and June 2014, 136 eligible patients (62.5% males) with a median age of 48.6 years, BMI of 29.6 kg/m2 and WC of 107.0 cm at enrolment were recruited by 21 dermatology hospital/private offices. All patients had received prior psoriasis treatment(s); 62.5% were biologic-naïve. Mean baseline psoriasis area severity index (PASI) and Dermatology Quality of Life Index (DLQI) scores were 23.4 ± 13.6 and 15.0 ± 8.3, respectively. A low correlation was observed between WC at enrolment and baseline PASI [ρ = 0.324 (P < 0.001)]. Over a median 48.4 weeks of infliximab exposure, 89.3% of the per protocol set achieved a PASI 75 response. At 14, 30 and 54 weeks, the PASI 75 attainment rate was 66.4%, 74.8% and 76.6%, respectively; the clinically meaningful DLQI improvement (≥5 point decrease) rate was 68.9%, 75.7% and 69.8%, respectively. BMI category and abdominal obesity at enrolment did not impact PASI 75 or DLQI improvement rate attainment. Conclusion: In the routine care of Greece, infliximab reduced disease activity and improved the quality of life of moderate-to-severe psoriasis patients through 1 year of treatment, independent of their BMI and WC. © 2018 European Academy of Dermatology and Venereolog